Loading clinical trials...
Loading clinical trials...
Evaluation of the Cost and Effectiveness in the First-line Treatment of Advanced Renal Cell Cancer With Sunitinib Compared to Interferon-alfa in Finland.
Conditions
Interventions
sunitinib
Locations
5
Finland
Kuopio University Hospital
Kuopio, Finland
Oulu Univeristy Hospital
Oulu, Finland
Tampere University Hospital
Tampere, Finland
Turku University Hospital
Turku, Finland
Vaasa Central Hosptital
Vaasa, Finland
Start Date
September 1, 2009
Primary Completion Date
November 1, 2013
Completion Date
December 1, 2013
Last Updated
February 6, 2014
NCT00026884
NCT07159659
NCT07485114
NCT07213804
NCT07169851
NCT07481851
Lead Sponsor
Pirkko-Liisa Kellokumpu-Lehtinen
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions